×
ADVERTISEMENT

2025 ASCO Annual Meeting

Structured Exercise Improves Survival in Stage II/III Colon Cancer

A structured exercise program after adjuvant chemotherapy in patients with high-risk stage II or III colon cancer ...

JUNE 16, 2025

Novel Therapy Found Effective for Polycythemia Vera in Phase 3 Trial

In an ongoing phase 3 trial, rusfertide (Takeda/Protagonist Therapeutics), a first-in-class hepcidin mimetic, ...

JUNE 16, 2025

New Treatment Strategy Proposed for Some Patients With HR-Positive, HER2-Negative Advanced Breast Cancer

SERENA-6 is the first global registration phase 3 trial to demonstrate the clinical utility of ctDNA monitoring to ...

JUNE 16, 2025

ASCO Meeting: Enhertu + Perjeta Potential First-Line Combo for Metastatic Breast Cancer

Trastuzumab deruxtecan combined with Perjeta may become first-line therapy for people with metastatic HER2-positive ...

JUNE 13, 2025

New Regimen for Localized Gastric Cancers Presented at ASCO

Adding the immunotherapy Imfinzi to standard chemotherapy improves outcomes for people with resectable gastric or ...

JUNE 12, 2025

FMT May Boost Immunotherapy Effectiveness, Overuse of Antibiotics Would Not

Fecal microbiota transplantation may enhance the effectiveness of immunotherapies by reducing gut dysbiosis, ...

JUNE 5, 2025

Load more